SUPPORTING INFORMATION
Service Specification – Enhanced Pharmaceutical Care Services v3 June 2024
SOP for Primary Care Supply of Enzalutamide for the Treatment of Prostate Cancer in Uro-Oncology Clinics (GGC) * PLEASE NOTE – SOP IS CURRENTLY UNDER REVISION (as of December 2022)
ORDER FORM
| BRAND NAME | GENERIC NAME | APPROVED SUPPLIER |
| Xtandi® | Enzalutamide | All orders must be placed with the manufacturer (Astellas) directly by telephone or email. Astellas Customer Service can be contacted on 0203 379 8721 or email ukcustomerservices@astellas.com Astellas Telephone: 0203 379 8721 Email: ukcustomerservices@astellas.com Fax: 0800 783 420528 days pack (112) Next Day Delivery If problems in accessing the medicine via this supply route cannot be resolved through direct dialogue with Astellas, contact the Health Board. Do not purchase from any other supply route without the approval of the Health Board |
OUT OF AREA HEALTH BOARD PARTICIPATION LISTS
Responsible Person: Mani Narwan
Last Updated: 05/06/25